LAURA WITHORNE-MALONEY: Open Payments
NPI 1255303707 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,209 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $154 |
| Alkermes, Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 3 | $51 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| HARMONY BIOSCIENCES LLC | 2 | $37 |
| ACADIA Pharmaceuticals Inc | 2 | $31 |
| Corium, LLC | 2 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, ARISTADA, INGREZZA, WAKIX, NUPLAZID, Auvelity, Azstarys, SPRAVATO.
Industry payments across SD — which companies pay providers there.
